This work developed an integrated experimental and computational pipeline for protein-level cell annotation and applied it to human PBMCs as an immune-cell test case, delivering an analytically benchmarked SCP workflow that resolves immune lineage and cell-state heterogeneity in human PBMCs and provides a classifier-ready, protein-level reference for immune-cell assignment.
Abstract
Single-cell proteomics (SCP) currently lacks validated benchmarking standards, and cell annotation often relies on transcriptomic proxies. Unsupervised clustering offers a proxy-free alternative, but its success depends on biological signal outweighing technical variation. In homogeneous samples this is achievable, but in heterogeneous populations, where closely related cell types differ only subtly, technical variation can dominate the clustering and obscure the biology needed for annotation. To address this, we developed an integrated experimental and computational pipeline for protein-level cell annotation and applied it to human PBMCs as an immune-cell test case. We isolated T cells, B cells, monocytes, and NK cells by negative-selection sorting to build a high-fidelity reference. In parallel, unsorted PBMCs from the same donor were processed on a cellenONE and acquired using label-free DIA on an Orbitrap Astral Zoom. Using the labeled reference dataset, we systematically benchmarked normalization, imputation, and clustering methods to assess their effect on cell-type separation. Unsupervised analysis resolved functional subpopulations within each lineage, and a probabilistic SCP classifier trained on these annotations identified the corresponding cell types and states in the unsorted PBMC fraction, validating the pipeline on unenriched, heterogeneous samples. Together, this work delivers an analytically benchmarked SCP workflow that resolves immune lineage and cell-state heterogeneity in human PBMCs and provides a classifier-ready, protein-level reference for immune-cell assignment.
Applied to very small human peripheral blood mononuclear cells, this work identifies up to 4000 proteins per cell, including key markers that distinguish monocytes, T cells, and activated lymphocytes within heterogeneous populations, underscoring that single-cell proteomics can now directly elucidate clinically relevan...
I. Hendriks, Sara C. Buch-Larsen, Martin Rykær et al.· Nature Communications· 0 citations
This Review systematically integrates current conceptual frameworks, computational methodologies, and domain-specific best practices for cell-type annotation in cardiovascular single-cell research and offers practical recommendations and discuss future directions encompassing multimodal integration, spatial transcripto...
Lu Sun, Li Ma, Li-Zhi Chen et al.· International Journal of Bio...· 0 citations
Accurate identification of cell types and states is essential for reliable single-cell RNA-sequencing analyses, yet current methods remain sensitive to continuous biological states, data preprocessing choices, and reference selection. Here we present ClustoCell, a reference-free method that resolves cell identity using...
Abbas Salavaty, M. Foroutan, N. Pretel et al.· bioRxiv· 0 citations
Integrative transcriptomic profiling identified peripheral T-cell dysregulation in CAP and highlighted CD8B, GZMM, MYL12B, and TUBA1A as candidate blood biomarkers.
Hua-Chi Jiang, Xiao-Qi Fan, Shu-Fang Zhou et al.· International Journal of Med...· 0 citations
Introduction B cells play essential roles in adaptive immunity by producing antigen-specific antibodies and interacting with T cells. Single-cell RNA and BCR sequencing technologies have enabled high-resolution dissection of B cell heterogeneity across diverse disease contexts. Atypical B cells (ABCs) display complex a...
R. Gan, Y. Zhong· Frontiers in Cell and Develo...· 0 citations